Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance, amount at Dec. 31, 2022 $ (17,885,387) $ 24,411 $ 17,575,396 $ (35,316,540) $ (168,654)
Beginning balance, shares at Dec. 31, 2022   24,411,098      
Net income 110,694     110,694  
Foreign currency translation gain (loss) 16,637       16,637
Stock-based compensation 244,923 $ 28 244,895    
Stock-based compensation, share   27,392      
Ending balance, amount at Mar. 31, 2023 (17,513,133) $ 24,439 17,820,291 (35,205,846) (152,017)
Ending balance, shares at Mar. 31, 2023   24,438,490      
Beginning balance, amount at Dec. 31, 2023 (18,243,421) $ 24,846 18,972,901 (37,124,126) (117,042)
Beginning balance, shares at Dec. 31, 2023   24,845,439      
Net income 208,908     208,908  
Foreign currency translation gain (loss) (30,394)       (30,394)
Stock options exercised 24,200 $ 20 24,180    
Stock options exercised, share   20,000      
Stock-based compensation 141,242 $ 45 141,197    
Stock-based compensation, share   45,243      
Ending balance, amount at Mar. 31, 2024 $ (17,899,465) $ 24,911 $ 19,138,278 $ (36,915,218) $ (147,436)
Ending balance, shares at Mar. 31, 2024   24,910,682